FDAFDA · Food and drugs·Recall number D-0112-2025
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37
Published December 11, 2024 · Recall initiated: October 25, 2024
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0305274664379
- Lot
- Lot: 23274856A, Exp 04/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.